Pharmacotherapy of sepsis

Clinics in Chest Medicine

Volumn 17, Issue 2, 1996, Pages 289-305

  Weikert, L F ^a   Bernard, G R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(3,4,5 TRIMETHOXYPHENYL)TETRAHYDROFURAN; 2,5 BIS(3,4,5 TRIMETHOXYPHENYL)TETRAHYDROTHIOPHENE; 6 (2 CHLOROPHENYL) 9 [(3,4 DIMETHOXYPHENYL)THIOMETHYLTHIOCARBONYL] 4,7,8,10 TETRAHYDRO 1 METHYLPYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; APAFANT; ASCORBIC ACID 2 OCTADECYL ETHER; ASCORBIC ACID 2 OCTYL ETHER; BRADYKININ ANTAGONIST; CATALASE; CORTICOSTEROID; DELTIBANT; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; GINKGOLIDE B; IBUPROFEN; NALOXONE; OPIATE ANTAGONIST; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; SDZ 64 688; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UBIQUINONE; UNCLASSIFIED DRUG; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

DRUG EFFECT; ENZYME INHIBITION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; STEROID THERAPY; SURVIVAL;

EID: 0029929775     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70315-4     Document Type: Article

References (157)

1. S. Adnot J. Lefort P. Braquet Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig Prostaglandins 32 1986 791 802
2. M.L. Alegre K. Gastaldello D. Abromowicz Pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome Transplantation 52 1991 674 690
3. O.I. Aruoma B. Halliwell B.M. Hoey The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid Free Radicals Biol Med 6 1989 593 597
4. J. Bakker H. Zhang M. Depierreux Effects of N-acetylcysteine in endotoxic shock J Crit Care 9 1994 236 243
5. R. Barthelson F.H. Valone R. Debs Synergy in interleukin 1 (IL-1) release by human monocytes stimulated with platelet-activating factor (PAF) plus γ-interferon (IFN-γ) or tumor necrosis factor (TNF) FASEB J 2 1988 1228
6. P.M.W. Bath D.G. Hassal A.-M. Gladwin Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro Arterioscler Thromb 11 1991 254 260
7. T.D. Baum S.O. Heard H.S. Feldman Endotoxin-induced myocardial depression in rat: Effect of ibuprofen and SDZ 64-688, a platelet-activating factor receptor antagonist J Surg Res 48 1990 629 634
8. G.R. Bernard N-Acetylcysteine in experimental and clinical acute lung injury Am J Med 91 1991 54S 59S
9. G.R. Bernard J.M. Luce C.L. Sprung High-dose corticosteroids in patients with the adult respiratory distress syndrome N Engl J Med 317 1987 1565 1570
10. G.R. Bernard W.D. Lucht M.E. Niedermeyer Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function J Clin Invest 73 1984 1772 1784
11. G.R. Bernard H.D. Reines P.V. Halushka Prostacyclin and thromboxane-A2 formation is increased in human sepsis syndrome: Effects of cyclooxygenase inhibition Am Rev Respir Dis 144 1991 1095 1101
12. P. Bessin J. Bonnet D. Apffel Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs Eur J Pharmacol 86 1983 403 413
13. H. Bessler R. Gilgal M. Djaldetti Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells J Leukoc Biol 40 1986 747 754
14. A.J. Bianco F.R. Appelbaum J. Nemunaitis Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation Blood 78 1991 1205 1211
15. B. Bonavida J.M. Mencia-Huerta P. Braquet Effects of platelet-activating factor on peripheral blood monocytes: Induction and priming for TNF secretion J Lipid Mediat 2 1990 S65 S76
16. R.C. Bone C.J. Fisher T.P. Clemmer A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 317 1987 653 658
17. F. Bonnet J. Bilaine F. Lhoste Naloxone therapy of human septic shock Crit Care Med 13 1985 972 975
18. D.J. Brackett M.R. Lerner M.F. Wilson Dimethyl-sulfoxide antagonizes hypotensive, metabolic, and pathologic responses induced by endotoxin Circ Shock 33 1991 156 163
19. P. Braquet L. Touqui T. Shen Perspectives in platelet-activating factor Pharmacol Rev 39 1987 97 145
20. K.L. Brigham Oxygen radicals—an important mediator of sepsis and septic shock Klin Wochenschr 69 1991 1004 1008
21. K.L. Brigham Role of free radicals in lung injury Chest 89 1986 859 863
22. K.L. Brigham B. Meyrick State of the art: Endotoxin and lung injury Am Rev Respir Dis 133 1986 913 927
23. K.L. Brigham B. Meyrick L.C. Berry Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin J Appl Physiol 63 1987 840 850
24. C.W. Broner J.L. Shenep G.L. Stidham Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice Crit Care Med 16 1988 848 854
25. K.A. Brown A.J. Collins Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro Ann Rheum Dis 36 1977 239 243
26. S.W. Chang S. Fernyak N.F. Voelkel Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury Am J Physiol 258 1990 H153 H158
27. R.M. Clancy J. Leszczynska-Piziak S.B. Abramson Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase J Clin Invest 90 1992 1116 1121
28. K.A. Clouse D. Powell I. Washington Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone J Immunol 142 1989 431 438
29. Cortech New Release: Phase II Bradycor trial does not show clinically meaningful reduction of 28-day mortality in sepsis 1994 Cortech Denver, CO
30. R. Daryani C. LaLonde D. Zhu Changes in catalase activity in lung and liver after endotoxemia in sheep Circ Shock 32 1990 273 280
31. A. DeMaria J.J. Heffernan G.A. Grindlinger Naloxone versus placebo in treatment of septic shock Lancet i 1985 1363 1365
32. B.J. Dezube J.L. Fridovich-Keil I. Bouvard Oxpentifylline and well-being in patients with cancer Lancet 335 1990 662
33. J.F. Dhainaut A. Tenaillon Y. Letulzo Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial Crit Care Med 22 1994 1720 1728
34. A. Etienne F. Hecquet C. Soulard In vivo inhibition of plasma protein leakage and Salmonella enteritidis -induced mortality in the rat by a specific PAF-acether antagonist: BN 52021 Agents Actions 17 1985 368 370
35. T.W. Evans G. Dent D.F. Rogers Effect of a PAF antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man Br J Pharmacol 94 1988 164 168
36. F. Fazely B.J. Dezube J. Allen-Ryan Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells Blood 77 1991 1653 1656
37. C. Ferran K. Sheehan R. Schreiber Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome Transplant Proc 23 1991 849 854
38. G.A. Fitzgerald A.K. Pedersen C. Patrono Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease Circulation 67 1983 1174 1177
39. J.F. Fletcher B.S. Di Simone M.A. Earnest Platelet-activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia Ann Surg 211 1990 312 316
40. J.S. Groeger G.C. Carlon W.S. Howland Naloxone in septic shock Crit Care Med 11 1983 650 654
41. A.B.J. Groeneveld W. den Hollander J. Straub Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock Circ Shock 30 1990 185 205
42. R.J. Gryglewski R.M.J. Palmer S. Moncada Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor Nature 320 1986 454 456
43. N.J. Gurll D.G. Reynolds J.W. Holaday Evidence for a role of endorphins in the cardiovascular pathophysiology of primate shock Crit Care Med 16 1988 521 530
44. K.V. Hackshaw G.A. Parker J.W. Roberts Naloxone in septic shock Crit Care Med 18 1990 47 51
45. S.A. Hamburger P.B. McCay Endotoxin-induced mortality in rats is reduced by nitrones Circ Shock 29 1989 329 334
46. P.J. Hanly D. Roberts K. Dobson Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia Lancet i 1987 351 354
47. B.G. Harbrecht T.R. Billiar J. Stadler Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia Crit Care Med 20 1992 1568 1574
48. P.M. Harrison J.A. Wendon A.E.S. Gimson Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure N Engl J Med 324 1991 1852 1857
49. J.E. Heffner S.A. Shoemaker E.M. Canham Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxame-A2 Chest 83 1983 78 85
50. A. Henderson P. Hayes Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: Potential new use for an old drug Ann Pharmacother 28 1994 1086 1088
51. L.B. Hinshaw B.K. Beller A.C.K. Chang Evaluation of naloxone for therapy of Escherichia coli shock: Species differences Arch Surg 119 1984 1410 1418
52. J.W. Holaday A.I. Faden Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock Brain Res 189 1980 295 300
53. J.W. Holaday A.I. Faden Naloxone reversal of endotoxic hypotension suggests role of endorphins in shock Nature 275 1978 450 451
54. E. Holler H.J. Kolb A. Moller Increased levels of tumor necrosis factor-α precede major complications of bone marrow transplantation Blood 75 1990 1011 1016
55. I.R. Hutcheson B.J.R. Whittle N.K. Boughton-Smith Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat Br J Pharmacol 101 1990 815 820
56. L.J. Ignarro P.J. Kadowitz The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation Annu Rev Pharmacol Toxicol 24 1985 171 191
57. L.J. Ignarro R.E. Byrns G.M. Buga Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical Circ Res 61 1987 866 879
58. C. Irle A.F. Salamin A. Bacigalupo Serum tumor necrosis factor levels during graft vs. host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 3 suppl 1988 127
59. M. Ito M. Baba S. Mori Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro Biochem Biophys Res Comm 166 1990 1095 1101
60. E.R. Jacobs M.E. Soulsby R.C. Bone Ibuprofen in canine endotoxin shock J Clin Invest 70 1987 536 541
61. T. Jensen A. Kharazmi P.O. Schiotz Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function APMIS 96 1988 62 67
62. S. Jepsen P. Herlevsen P. Knudsen Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study Crit Care Med 20 1992 918 923
63. H.B. Kaplan H.S. Edelson H.M. Korchak Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo Biochem Pharmacol 33 1984 371 378
64. R. Kopolovic K.M. Thraikill D.T. Martin Effects of ibuprofen on a porcine model of acute respiratory failure J Surg Res 36 1984 300 305
65. S. Koyama T. Kobayshi K. Kubo Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep Am Rev Respir Dis 145 1992 1404 1409
66. M. Kretzschmar Role of oxygen free radicals in the pathophysiology of sepsis K. Reinhart K. Eyrich C. Sprung Sepsis: Current Perspectives in Pathophysiology and Therapy 1994 Springer-Verlag Berlin 122 135
67. F. Kunimoto T. Morita T. Fujita Inhibition of lipid peroxidation improves survival rate of endotoxemic rats Circ Shock 21 1987 15 22
68. G. Leimenstoll P. Zabel P. Schroeder Suppression of OKT3-induced tumor necrosis factor-α formation by pentoxifylline in renal transplant recipients Transplant Proc 25 1993 561 563
69. J.L. Lelli R.A. Drongowski B. Gastman Effects of coenzyme Q10 on the mediator cascade of sepsis Circ Shock 39 1993 178 187
70. J.M. Luce A.B. Montgomery J.D. Marks Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock Am Rev Respir Dis 138 1988 62 68
71. W.D. Lucht D.K. English G.R. Bernard Prevention of release of granulocyte aggregants into sheep lung lymph following endotoxemia by N-acetylcysteine Am J Med Sci 294 1987 161 167
72. R. Mann L.C. Woodson L.D. Traber Role of bradykinin in ovine endotoxemia Circ Shock 34 1991 224 230
73. T. Matsuda C.A. Eccleston I. Rubinstein Antioxidants attenuate endotoxin-induced microvascular leakage of macromolecules in vivo J Appl Physiol 70 1991 1483 1489
74. K. McKechnie B.L. Furman J.R. Parratt Modification by oxygen free radical scavengers of the metabolic and cardiovascular effects of endotoxin infusion in conscious rats Circ Shock 19 1986 429 439
75. A.A. McKnight W.G. Keyes M.L. Hudak Oxygen free radicals and the cerebral arteriolar response to group B streptococci Pediatr Res 31 1992 640 644
76. A. Meister On the antioxidant effects of ascorbic acid and glutathione Biochem Pharmacol 44 1992 1905 1915
77. H.R. Michie K.R. Manogue D.R. Spriggs Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 318 1988 1481 1486
78. S.A. Milligan J.M. Hoeffel I.M. Goldstein Effect of catalase on endotoxin-induced acute lung injury in unanesthetized sheep Am Rev Respir Dis 137 1988 420 428
79. J. Modig R. Sandin Haematological, physiological and survival data in a porcine model of adult respiratory distress syndrome induced by endotoxaemia Acta Chir Scand 154 1987 169 177
80. T. Mozes F.J. Zijlstra J.P.C. Heiligers Sequential release of TNF, PAF and eicosanoids during endotoxin shock in anesthetized pigs; protective effects of indomethacin Br J Pharmacol 104 1991 691 699
81. P.R. Myers R.L. Minor Jr R. Guerra Jr Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide Nature 345 1990 161 163
82. A. Nonaka T. Manabe T. Tobe Effect of a new synthetic free radical scavenger, 2-octadecyl ascorbic acid, on the mortality in mouse endotoxemia Life Sci 47 1990 1933 1939
83. B.J. Northover G. Subramanian Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs J Pathol Bacteriol 83 1962 463 468
84. G.P. Novelli Oxygen radicals in experimental shock: Effects of spin-trapping nitrones in ameliorating shock pathophysiology Crit Care Med 20 1992 499 507
85. M. Ogletree C. Begley G. King Influence of steroidal and nonsteroidal anti-inflammatory agents on accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep: Measurements of prostacyclin and thromboxane metabolites and 12-HETE Am Rev Respir Dis 133 1986 55 61
86. N.C. Olson D.L. Anderson M.K. Grizzle Dimethylthiourea attenuates endotoxin-induced acute respiratory failure in pigs J Appl Physiol 63 1987 2426 2432
87. L. Otterbein V.C. Lowe D.J. Kyle Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsis Agents Actions 39 1993 C125 C127
88. E.R. Pacht A.P. Timerman M.G. Lykens Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome Chest 100 1991 1397 1403
89. R.M.J. Palmer A.G. Ferrige S. Moncada Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor Nature 327 1987 524 526
90. P.L. Peavy E.J. Fairchild Evidence for lipid peroxidation in endotoxin-poisoned mice Infect Immunol 52 1986 613 616
91. J.G. Peralta S. Liesuy P. Evelson Oxidative stress in skeletal muscle during sepsis in rats Circ Shock 39 1993 153 159
92. M.B. Perlman A. Johnson A.B. Malik Ibuprofen prevents thrombin-induced lung vascular injury: Mechanism of effect Am J Physiol 252 1987 H605 H614
93. W.P. Peters M.W. Johnson P.A. Friedman Pressor effect of naloxone in septic shock Lancet i 1981 529 532
94. H.-W. Pfister U. Koedel S. Lorenzl Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats Stroke 23 1992 1798 1804
95. P.F. Piguet G.E. Grau M. Collart Graft vs. host reaction induces an alveolitis involving tumor necrosis factor-α Bone Marrow Transplant 3 suppl 1988 111
96. H.W. Pogrebniak M.J. Merino S.M. Hahn Spintrap salvage from endotoxemia: The role of cytokine downregulation Surgery 112 1992 130 139
97. R.J. Powell G.W. Machiedo B.F. Rush Oxygen free radicals: Effect on red cell deformability in sepsis Crit Care Med 19 1991 732 735
98. C. Putterman P. Halpern Y. Leykin Early use of naloxone in shock—a clinical trial Resuscitation 13 1986 185 190
99. R. Rabinovici T.L. Yue M. Farhat Platelet-activating factor (PAF) and tumor necrosis factor-α (TNF-α) interactions in endotoxemic shock: Studies with BN 50739, a novel PAF antagonist J Pharmacol Exp Ther 255 1990 256 263
100. M. Rees J.C. Bowen J.G. Payne Plasma β-endorphin immunoreactivity in dogs during anesthesia, surgery, Escherichia coli sepsis, and naloxone therapy Surgery 93 1983 386 390
101. D.G. Reynolds N.J. Gurll T. Vargish Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock Circ Shock 7 1980 39 48
102. J.E. Rinaldo B. Pennock Effects of ibuprofen on endotoxin-induced alveolitis Am J Med Sci 291 1986 29 38
103. P. Rock H. Silverman D. Plump Efficacy and safety of naloxone in septic shock Crit Care Med 13 1985 28 33
104. A.C. Rosam J.L. Wallace B.J.R. Whittle Potent ulcerogenic actions of PAF on the stomach Nature 319 1986 54 55
105. C.A. Rouzer W.A. Scott A.L. Hamill Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages J Exp Med 155 1982 720 733
106. G.M. Rubanyi P.M. Vanhoutte Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor Am J Physiol 250 1986 H822 H827
107. S. Saeki F. Masugi T. Ogihara Effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine (platelet-activating factor) on cardiac function in perfused guinea pig heart Life Sci 37 1985 325 329
108. M. Safani J. Blair D. Ross Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock Crit Care Med 17 1989 1004 1009
109. R. Sala E. Moriggi G. Corvasce Protection by N-acetylcysteine against pulmonary endothelial cell damage induced by oxidant injury Eur Respir J 6 1993 440 446
110. H. Salari M. Demos A. Wong Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat Circ Shock 32 1990 189 207
111. W.L. Salzer C.E. McCall Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet-activating factor induces enhanced production of thromboxane and lung injury J Clin Invest 85 1990 1135 1143
112. F.U. Schade Pentoxifylline increases survival in murine endotoxin shock and decreases TNF formation Circ Shock 31 1990 171 181
113. F.U. Schade J. von der Bosch M.M. Schonharting Pentoxifylline increases survival of mice in endotoxin shock K. Schror H. Sinzinger Prostaglandins in Clinical Research 1989 AR Liss New York 223 227
114. P. Schandene P. Vandenbussche A. Crusiaux Differential effects of pentoxifylline on the production of tumor necrosis factor-α and interleukin-6 by monocytes and T-cells Immunology 76 1992 30 34
115. D. Schlondorff D.A. Neuwirth PAF and the kidney Am J Physiol 251 1986 F1 F11
116. E.A. Schmalzer S. Chien Filterability of subpopulations of leukocytes: Effect of pentoxifylline Blood 64 1984 542 544
117. J. Schneider E. Friderichs K. Heintze Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats Circ Shock 30 1990 97 106
118. A. Seekamp C. LaLonde D. Zhu Catalase prevents prostanoid release and lung lipid peroxidation after endotoxemia in sheep J Appl Physiol 65 1988 1210 1216
119. H.M. Shanies L. Kaufman E.C. Fletcher CP-0127 (Bradycor), a bradykinin antagonist, in SIRS and sepsis: Results from the second multicenter trial using a 7-day infusion Chest 108 suppl 1995 119S
120. C. Shindoh A. Dimarco D. Nethery Effect of PEG-superoxide dismutase on the diaphragmatic response to endotoxin Am Rev Respir Dis 145 1992 1350 1354
121. Y. Shinozawa C. Hales W. Jung Ibuprofen prevents synthetic smoke-induced pulmonary edema Am Rev Respir Dis 134 1986 1145 1148
122. M. Siebeck J. Weipert M. Jochum A new triazolodiazepine platelet-activating factor receptor antagonist reduces pulmonary dysfunction in endotoxin shock of the pig [abstract] Am Rev Respir Dis 139 1989 29
123. J.R. Snapper A.A. Hutchison M.L. Ogletree Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep J Clin Invest 72 1983 63 76
124. F. Snyder Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether-linked choline-phopholipids Med Res Rev 5 1985 107 140
125. M.E. Soulsby E.R. Jacobs B.H. Perlmutter Protection of myocardial function during endotoxin shock by ibuprofen Prostaglandins, Leukotrienes and Medicine 13 1984 295 305
126. 2 consumption and gastric intramucosal pH in septic patients Crit Care Med 21 1993 S183
127. R.S. Sprague A.H. Stephanson T.E. Dahms Effects of ibuprofen on the hypoxemia of established ethchlorvynol-induced unilateral acute lung injury in anesthetized dogs Chest 92 1987 1088 1093
128. R.M. Strieter D.G. Remick P.A. Ward Cellular and molecular regulation of tumor necrosis factor-α production by pentoxifylline Biochem Biophys Res Commun 155 1988 1230 1236
129. K. Sugino K. Dohi K. Yamada The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effects of antioxidants Surgery 101 1987 746 752
130. P.M. Suter G. Domenighetti M.-D. Schaller N-Acetylcysteine enhances recovery from acute lung injury in man: A randomized, double-blind, placebo-controlled clinical study Chest 105 1994 190 194
131. N. Suttorp S. Kastle H. Neuhof Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia Lung 169 1991 203 214
132. C.S. Tannenbaum T.A. Hamilton Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP J Immunol 142 1989 1274 1280
133. R.M. Tate H.G. Morris W.R. Schroeder Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs J Clin Invest 74 1984 608 613
134. Tenaillon A, Dhainaut JF, Boiteau R: Tolerance of PAF antagonist (BN 52021) in patients with septic shock. Intensive Care Med, in press
135. Z. Terashita S. Taushima Y. Yoshioka CV-3988—a specific antagonist of platelet-activating factor (PAF) Life Sci 32 1983 1975 1981
136. C.S. Tseng H.S. Tso Effects of opioid agonists and opioid antagonists in endotoxic shock in rats Ma Tsui Hsueh Tsa Chi Anaesthesiologica Sinica 31 1993 1 8
137. P. Vallance S. Moncada Role of endogenous nitric oxide in septic shock New Horizons 1 1993 77 86
138. J.R. Vane E.E. Anggard R.M. Botting Regulatory functions of the vascular endothelium N Engl J Med 323 1990 27 36
139. G.M. Vercelotti H.Q. Yin K.S. Gustafson Platelet activating factor primes neutrophil responses to agonists: Role in promoting neutrophil-mediated endothelial damage Blood 71 1988 1100 1106
140. Veterans Administration Systemic Sepsis Cooperative Group The effects of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis N Engl J Med 317 1987 659 665
141. A. Waage M. Sorensen B. Stordal Differential effect of oxpentifylline on tumor necrosis factor and interleukin-6 production Lancet 335 1990 543
142. J.L. Wallace B.J.R. Whittle Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor Eur J Pharmacol 124 1986 209 210
143. J. Wang M.J. Dunn Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats Am J Physiol 253 1987 F1283 F1289
144. T. Wegener B. Sandhagen T. Saldeen Effect of N-acetylcysteine on pulmonary damage due to microembolism in the rat Eur J Respir Dis 70 1987 205 212
145. T. Wegener R. Wallin T. Saldeen Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation Ups J Med Sci 91 1986 45 52
146. C.H. Welsh D. Lien G.S. Wothen Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog Am Rev Respir Dis 138 1988 1106 1114
147. E.T. Whalley J.A. Solomon D.M. Modafferi CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock Agents Actions Suppl 38 1992 413 420
148. C.E. Wright D.D. Rees S. Moncada Protective and pathological roles of nitric oxide in endotoxin shock Cardiovasc Res 26 1992 48 57
149. P.W. Wright G.R. Bernard Effects of metaproterenol, atropine and ibuprofen on lung function during the late phase of endotoxemia in sheep Am Rev Respir Dis 137 1988 179
150. P.W. Wright G.R. Bernard Mechanisms of late hemodynamic and airway dynamic responses to endotoxin in awake sheep Am Rev Respir Dis 140 1989 672 678
151. K. Yasumoto Y. Inada Effect of coenzyme Q10 on endotoxin shock in dogs Crit Care Med 14 1986 570 574
152. Y.-K. Youn C. LaLonde R. Demling Use of antioxidant therapy in shock and trauma Circ Shock 35 1991 245 249
153. T.L. Yue M. Farhat R. Rabinovici Protective effect of BN 50739 a new PAF antagonist in endotoxin-treated rabbits J Pharmacol Exp Ther 254 1990 976 981
154. P. Zabel U. Greinert P. Entzian Effects of pentoxifylline on circulating cytokines (TNF and IL-6) in severe pulmonary tuberculosis Eur Cytokine Network 3 1992 248A
155. P. Zabel D.T. Wolter M.M. Schonharting Oxpentifylline in endotoxaemia Lancet 1334 1989 1474 1477
156. H. Zhang H. Spapen D.N. Nguyen Protective effects of N-acetyl-L-cysteine in endotoxemia Am J Physiol 266 1994 H1746 H1754
157. J.J. Zimmerman Potential of oxyradical scavengers in the therapy of sepsis K. Reinhart K. Eyrich C. Sprung Sepsis: Current Perspectives in Pathophysiology and Therapy 1994 Springer-Verlag Berlin 414 424